To view the PDF file, sign up for a MySharenet subscription.

DIS-CHEM PHARMACIES LIMITED - Dealing in Dis-Chem shares pursuant to an employee Share Scheme

Release Date: 06/02/2023 16:10
Code(s): DCP     PDF:  
Wrap Text
Dealing in Dis-Chem shares pursuant to an employee Share Scheme

Dis-Chem Pharmacies Limited
(Incorporated in the Republic of South Africa)
(Registration number 2005/009766/06)
JSE share code: DCP
ISIN: ZAE000227831
(“Dis-Chem” or the “Company”)


DEALING IN DIS-CHEM SHARES PURSUANT TO AN EMPLOYEE SHARE SCHEME



Shareholders of Dis-Chem are advised of the following dealings in the Company’s securities due to the
exercise of the Share Appreciation Rights options.

In compliance with sections 3.63 to 3.74 of the Listings Requirements of the JSE Limited, the following
information is disclosed:

 Name of Director:                                  Mr Stanley Goetsch
 Nature and extent of interest:                     Direct
 Class of securities:                               Ordinary shares
 Number of Share Appreciation Rights exercised:     58 933
 Resulting number of shares received:               3 190
 Price per security:                                R29.8446
 Total value of transaction:                        R95 204.27
 Nature of transaction:                             Exercise of Share Appreciation Rights previously
                                                    awarded in terms of the Share Appreciation Rights
                                                    Plan
 Award date:                                        01 June 2018
 Date of transaction:                               03 February 2023


Clearance for the above transaction was obtained in accordance with Dis-Chem’s trading policy.

Midrand

6 February 2023

Sponsor

The Standard Bank of South Africa Limited

Date: 06-02-2023 04:10:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story